The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Updated COVID-19 shots, including ...

More than three-quarters of American adults didn't get a COVID shot last season, a figure that health care experts warn could ...

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines. Two recent studies from the Centers for Disease Control and Prevention’s ...

A majority of Americans say childhood vaccines are effective at preventing illness, but slightly fewer are confident that the ...

Nearly one in four people may not get COVID-19 vaccines until at least 2022 because rich countries with less than 15% of the global population have reserved 51% of the doses of the most promising ...

Every time Catherine publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...